Home > Archive > Lupus Support > December 2005 > Difficult-to-Manage Lupus





You are viewing an archived Text-only version of the thread. To view this thread in it's original format and/or if you want to reply to this thread please [click here]

Author Difficult-to-Manage Lupus
J

2005-12-23, 11:00 am

http://www.lupusmn.org/Education/Ar...ManageLupus.htm (no
date there)
Difficult-to-Manage Lupus

Having treated over 2,000 lupus patients over the last 20 years, I was
intrigued when the editor of Lupus Update asked me to write about
“Difficult to Manage Lupus.” After all, isn't all lupus difficult to
manage? However, there are certain situations that are more difficult to
manage than others. Ten patient cases are presented here:


When not to overtreat? Resistant non-organ-threatening disease?

A patient with Systemic Lupus Erythematosus (SLE) has persistently active
rashes, fevers, fatigue and pain on taking a deep breath despite
nonsteroidals and Plaquenil. There is no evidence for heart, lung,
liver, central nervous system, hematologic or renal involvement. There
are circumstances when certain treatments often do more harm than good if
oral steroids or methotrexate are added in this situation, so I might try
a few other things first. Consider increasing Plaquenil, consider DHEA,
use very high dose nonsteroids or a local one-time only steroid boost.


Cyclophosphamide (Cytoxan) resistant lupus nephritis

Fifteen to twenty percent of all individuals with SLE have lupus in their
kidneys and biopsies showing proliferative disease. With no treatment,
they will be on dialysis within 2-3 years. Although Cytoxan is the
treatment of choice for them, this toxic therapy does not work or wears
off 30-40 percent of the time. What do I do? My options include:
consider adding azathioprine (Imuran) to the Cytoxan and continue
treatments; add plasmapheresis or pulse-dose steroids; or substitute
nitrogen mustard for Cytoxan. Consider rebiopsying the patient and make
sure that the renal lesion is reversible. Sometimes, it's better to let
a patient go on to dialysis and transplant them than treat them further.
Newer treatments may be utilized: cyclosporin, mycophenolate mofetil
(CellCept) or tacrillimus (Prograf, FK 506). Drug trials with LJP394 and
Biogen's antiCD40 ligand are available at selected medical centers.


Refractory chronic cutaneous lupus with no systemic disease

A patient has lupus rashes covering 70 percent of the body, but their ANA
is negative and all blood work is normal. Plaquenil has not helped. I
have had some success with: switching from Plaquenil to Chloroquine and
adding quinacrine, retinoids such as Accutante or Soriatene; antileprosy
drugs including thalidomide, clofazimine or dapsone; topical nitrogen
mustard or BCNU.


Lifestyle-altering central nervous system (CNS) symptoms with a normal MRI
scan of the brain and blood tests showing slight activity

When my patients complain about not thinking clearly, severe headaches and
profound fatigue, the issue is raised as to whether it could be vasculitis
of the CNS. True CNS vasculitis in SLE is usually obvious (e.g., fevers,
meningitis-like picture, psychosis, seizures), and responds to high dose
steroids. But could the patient have “subclinical vasculitis?” In
fact, this is rare and most often the symptoms are due to abnormal blood
flow to the brain due to a dysfunction of the autonomic nervous system and
/ or the dysfunction of chemicals known as cytokines (interleukins,
interferons, etc.). I frequently order a SPECT scan (which might include
antineural antibodies) and antiribosomal P antibodies and a spinal tap.
Make sure that your doctor obtains LE cells, oligoclonal bands,
antineuronal antibodies and IgG synthesis rate in addition to the usual
determinations.


Cognitive impairment in patients without CNS vasculitis

How do we treat the patient in number 4 (above) who does not have
vasculitis? Interventions are useful that improve the blood flow to the
brain regulated by the autonomic nervous system (which controls the
dilation or constriction of blood vessels, thus regulating our pulse and
blood pressure), such as: biofeedback, relaxation techniques, cognitive
therapy and counseling. Additionally, serotonin boosters (Prozac,
Zoloft, Paxil) may help give a patient more energy and clarity.
Antimalarials (Plaquenil, quinacrine) and DHEA can be useful. Steroids
may seem to help at first but make things worse in the long run and should
be avoided unless there is evidence for inflammation.


More than one miscarriage in a patient without anticardiolipin antibodies

Antiphospholipid antibodies and the circulating lupus anticoagulant can
cause miscarriages. Most primary care doctors stop the workup after
obtaining a negative anticardiolipin antibody and circulating
anticoagulant test and don't treat the patient. On the other hand,
aggressive reproductive immunologists unnecessarily treat patients with
expensive and toxic approaches such as heparin, prednisone and intravenous
gamma globulin for subsequent pregnancies which would be successful in any
case. Active lupus by itself can cause miscarriages. I'm in the
middle. I check for three to four different phospholipid antibodies,
Protein C, Protein S, antithrombin III, Factor V Leiden mutation, BDRL and
kaolin PTTs.


Is the muscle and joint aching a lupus flare or fibromyalgia?

Fibromyalgia can be as discomforting as lupus-associated inflammation but
is made worse by corticosteroids. It is important not to inappropriately
treat. I generally only treat symptoms of lupus with higher doses of
anti-inflammatory medicine when there is objective evidence of joint
swelling (synovitis), a high CPK (muscle enzyme), a high sed rate or CRP
(blood tests for inflammation), low C3 complement or high anti-DNA.
Lacking this, sometimes I have had to resort to obtaining a bone scan to
assess if somebody with profound musculoskeletal discomfort and SLE is
inflamed or experiencing a flare or fibromyalgia. The latter is treated
with tricyclics, serotonin boosters and muscle relaxants and is seen in 25
percent of lupus patients.


The patients with non-organ threatening disease who want to treat their
disease “naturally”

Twenty percent of patients with non-organ threatening disease will evolve
organ threatening disease over five years, but this percentage decreases
to five percent with two years of Plaquenil. No herb or spice has been
shown to be specifically effective for SLE, and studies are sorely
needed. None of these preparations, marketed as nutritional supplements
to avoid FDA regulation, are standardized. Avoid believing testimonials
and only rely on peer-reviewed published controlled studies. Let the
buyer beware.



My eight-year-old daughter has aches and a positive ANA. Should I be
worried?

Ten percent of women with SLE will have a daughter with the disease, and
two percent a son with it. Twenty percent with SLE will have an
offspring with an autoimmune disorder (most commonly autoimmune thyroid
disease). Fifty percent of children of lupus patients have a positive
ANA. Girls who are prepubertal develop lupus very rarely. Their
positive ANA is inherited and their aches are usually due to growing
pains. We usually advise against ANA or antibody testing unless there is
objective evidence for a problem such as a fever, swollen joints or rash.


The 70-year-old woman with a diagnosis of new-onset lupus

Ten percent of the population develops ANAs as they age. When senior
citizens are found to have a positive ANA and have a high sedimentation
rate and joint aches, they often come to rheumatologists with a diagnosis
of lupus. In reality, the overwhelming majority do not have the
disease. Polymyalgia rheumatica, fibromyalgia, rheumatoid arthritis and
particularly Sjogren's syndrome need to be ruled out.


By Daniel J. Wallace, MD, Clinical Professor of Medicine, UCLA School of
Medicine. Reprinted with permission from the Maryland Lupus
Foundation. Dr. Wallace is the author of “The Lupus Book: A Guide for
Patients and their Families”.

Copyright 2003 - 2008 pahealthsystems.com